NTX blood bank reagent
Ended Awarded Last action
- Contract number
- 36C25722N0387
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $19,174
Award facts
- Contract value 96% obligated
-
- $19,173.91 Current, with exercised options
- $20,028.18 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Dallas, TX 75216, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$159 | |
| Supplemental Agreement for work within scope | -$854 | |
| Original award | $20,187 |
About this award
Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and reagents, received a delivery order valued at approximately $20K for blood bank reagents under a Blanket Purchase Agreement (BPA) with the Veterans Integrated Service Network 17 (VISN 17). The contract was awarded on August 1, 2022, with an ultimate completion date of December 30, 2023, and operates under a firm fixed-price structure. This award falls under the parent GSA Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII), which provides federal agencies with streamlined procurement mechanisms for diagnostic supplies. The contract is not designated as a small business set-aside.
This delivery order represents a call against Werfen's broader BPA framework with the Veterans Health Administration, which has consistently utilized the contractor's diagnostic equipment and reagent portfolio across multiple VISNs. The Veterans Integrated Service Network 17, which serves the Dallas, Texas area, procured these blood bank reagents to support diagnostic testing operations at Veterans Affairs medical treatment facilities. Werfen's extensive federal contracting history with the VA and other agencies such as the Defense Health Agency and Indian Health Service demonstrates the contractor's established capacity to deliver clinical laboratory consumables and support services on a cost-effective basis.
Quick answers
Who was awarded contract 36C25722N0387?
36C25722N0387 was awarded to Werfen USA LLC by Veterans Integrated Service Network 17 (Veterans Health Administration) on August 1, 2022.
How much is contract 36C25722N0387 worth?
The government has obligated $19,174 on 36C25722N0387. Its potential value, with all options, is $20,028.
Is contract 36C25722N0387 an order under another contract?
Yes. 36C25722N0387 is a BPA call under V797D70110-36C25722A0028, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25722N0387 competed?
The extent of competition for 36C25722N0387 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award